Sandbox Reserved 1713: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
In order for the Anaplastic Lymphoma Kinase (ALK) to move across the membrane to bind with the second monomer, it has to undergo a conformational change. The Anaplastic Lymphoma Kinase Activating Ligand (ALKAL) binds to the binding surface on the ALK. This induces a conformational change which allows for the PXL and the GlyR domains to hinge forward. <ref>DOI: 10.1038/s41586-021-04140-8</ref> The kinase is now ready to move across the membrane and attach to the other kinase to be fully activated. | In order for the Anaplastic Lymphoma Kinase (ALK) to move across the membrane to bind with the second monomer, it has to undergo a conformational change. The Anaplastic Lymphoma Kinase Activating Ligand (ALKAL) binds to the binding surface on the ALK. This induces a conformational change which allows for the PXL and the GlyR domains to hinge forward. <ref>DOI: 10.1038/s41586-021-04140-8</ref> The kinase is now ready to move across the membrane and attach to the other kinase to be fully activated. | ||
== Disease == | == Disease == | ||
<scene name='90/904318/Premutationresidues/ | <scene name='90/904318/Premutationresidues/2'>mutated residues</scene> | ||
== Relevance == | == Relevance == | ||
Revision as of 23:25, 27 March 2022
| This Sandbox is Reserved from February 28 through September 1, 2022 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1700 through Sandbox Reserved 1729. |
To get started:
More help: Help:Editing |
Anaplastic Lymphoma Kinase
| ||||||||||||

